DeepWork Capital is a venture capital firm investing in early stage companies in Florida and surrounding regions. DeepWork’s team consists of venture investors and technology founders who aim at helping entrepreneurs become disruptive leaders in their industries.
DeepWork starts their partnership with companies in their first institutional round. Then, they allocate additional capital to support their continued growth.
DeepWork invests in technology companies that provide disruptive solutions in areas demonstrating favorable macro-economic trends including mobile and cloud computing, health care technology, on-demand services, and demographic focused business solutions.
DeepWork launched their first fund in 2015 to invest in the Florida early stage pipeline. The company is an active investor and prefers to take a lead or co-lead role, but also syndicates with other partners.
Aegle Therapeutics Corporation, a regenerative medicine company isolating extracellular vesicles ("EVs") from allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat severe dermatological conditions, including burns and epidermolysis bullosa (“EB”).